Clinical Trials in Georgia

Showing 1881-1900 of 19,050 trials

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

NCT03541889

The purpose of this study is to find new tests that could help determine if the newly infused bone marrow cells are growing well after bone marrow transplantation or if new bone marrow cells are needed. The Investigator will use FLT imaging, an investigational imaging test, and collect blood samples to investigate whether the cells are growing well.

Primary Graft Failure

University of Oklahoma56 participantsStarted Feb 2021

Atlanta, Georgia, United States • Ann Arbor, Michigan, United States • Cleveland, Ohio, United States +1 more locations

RECRUITINGPhase 2/365 miles

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

NCT05816382

The main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK-861.

Narcolepsy Type 1

Takeda500 participantsStarted Apr 2023

Birmingham, Alabama, United States • Redwood City, California, United States • Santa Ana, California, United States +49 more locations

REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Find Trials by Condition in Georgia

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Light Therapy for PD - Dose Selection

Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes